share_log

英科医疗(300677.SZ):拟斥1.3亿元参投常州云常股权投资中心(有限合伙)

Yingke Medical (300677.SZ): plans to invest 130 million yuan to invest in Changzhou Yunchang Equity Investment Center (limited partnership)

格隆滙 ·  Nov 19, 2021 16:20

300677.SZ announced that Yingke Hong Kong, a wholly owned subsidiary of the company, plans to set up QFLP, which is Yunzhuang Venture Capital Center (Limited Partnership) in Guangxi Free Trade Zone (referred to as "Guangxi Yunzhuang"), through the qualified overseas Limited partner ("QFLP") mechanism. Guangxi Yunzhuang will participate as one of the limited partners in investing in the third phase of the RMB fund managed by Shanghai Yunpan Investment Management Co., Ltd., that is, Changzhou Yunchang Equity Investment Center (limited partnership) and other partnerships that invest in parallel (referred to as "partnership").

The total amount of capital subscribed by the partnership enterprise is RMB 1.2 billion yuan, the maximum amount of capital contribution is no more than RMB 1.8 billion yuan, and the amount of capital subscribed in this round is no more than RMB 700 million yuan. The company will subscribe 130 million yuan to invest in the partnership through Yunzhuang, Guangxi.

Changzhou Yunchang investment objectives, areas and strategies: a new generation of information technology industry (including information technology services, artificial intelligence, etc.), high-end equipment manufacturing industry and other technology and industrial digitization; partnerships will mainly invest in enterprises in the early and middle stages.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment